On May 30, 2023, Enzo Biochem, Inc. filed documents with the Securities and Exchange Commission announcing that the company experienced a ransomware attack resulting in millions of patients’ information being compromised. Based on the company’s official filing, the incident resulted in an unauthorized party gaining access to consumers’ names, Social Security numbers and clinical test information….
By: Console and Associates, P.C.
By: Console and Associates, P.C.